Sara Margolis represents clients in complex commercial litigation, particularly in the pharmaceuticals and life sciences sectors.
Sara draws on substantial trial and case management experience to represent companies and investors in high-stakes disputes in federal and state courts. She regularly represents clients on a range of matters involving:
- Antitrust litigation
- Bankruptcy-related disputes
- Breach of contract claims
- Fraud and securities litigation, including class actions
- Intellectual property disputes
She handles contested proceedings through verdict and appeal, bringing a pragmatic, trial-ready approach to litigation across the financial services, biotech, and healthcare industries.
Sara also regularly helps companies and their boards navigate concurrent class actions and government inquiries. She leverages a commercial perspective to manage complex, multi-forum disputes — including coordinating discovery, motion practice, and trial teams — to position cases for favorable outcomes in and out of the courtroom.
Before joining Latham, Sara was a partner at a litigation firm in New York. She previously clerked for Judge Vincent L. Briccetti of the US District Court for the Southern District of New York.